Oxford Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-550
| Closed | -$349K | – | 703 |
|
|
2025
Q1 | $349K | Buy |
550
+207
| +60% | +$131K | 0.17% | 206 |
|
|
2024
Q4 | $244K | Buy |
+343
| New | +$244K | 0.11% | 305 |
|
|
2024
Q1 | – | Sell |
-704
| Closed | -$618K | – | 337 |
|
|
2023
Q4 | $618K | Buy |
+704
| New | +$618K | 0.93% | 24 |
|
|
2020
Q1 | – | Sell |
-4,252
| Closed | -$1.6M | – | 1058 |
|
|
2019
Q4 | $1.6M | Buy |
+4,252
| New | +$1.6M | 0.04% | 562 |
|
|
2019
Q3 | – | Sell |
-1,214
| Closed | -$380K | – | 1911 |
|
|
2019
Q2 | $380K | Sell |
1,214
-18,929
| -94% | -$5.93M | 0.01% | 1375 |
|
|
2019
Q1 | $8.27M | Buy |
+20,143
| New | +$8.27M | 0.18% | 122 |
|
|
2018
Q4 | – | Sell |
-769
| Closed | -$312K | – | 2040 |
|
|
2018
Q3 | $312K | Sell |
769
-364
| -32% | -$148K | 0.01% | 1484 |
|
|
2018
Q2 | $393K | Sell |
1,133
-1,766
| -61% | -$613K | 0.01% | 1423 |
|
|
2018
Q1 | $998K | Buy |
2,899
+143
| +5% | +$49.2K | 0.02% | 940 |
|
|
2017
Q4 | $1.05M | Buy |
+2,756
| New | +$1.05M | 0.02% | 904 |
|
|
2014
Q4 | – | Sell |
-5,733
| Closed | -$2.06M | – | 767 |
|
|
2014
Q3 | $2.06M | Buy |
+5,733
| New | +$2.06M | 0.05% | 366 |
|